| BIOGEN INC | 233.40 / +5.21% |
| Date/Time | 03/08 / 17:32 |
| Chg. / Chg.(%) | 11.55 / +5.21% |
| Bid | - |
| Ask | - |
| Open | 225.20 |
| Previous Close | 221.85 |
| High | 233.40 |
| Low | 224.85 |
| Volume [EUR] | 62,591.35 |
| Volume [Units] | 275 |
| Price fixings | 16 |
| ISIN | US09062X1037 |
| Security | BIIB |
| Exchange | Vienna Global Market |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 270.0100 |  |
1,163,675 |
| IEX | 270.20 | |
65,885 |
| Cboe US | 270.20 | |
56,356 |
| London Inter.. | 277.18 |  |
1,308 |
| Xetra | 233.05 | |
1,176 |
| TradeGate | 230.450 | |
1,014 |
| Vienna Globa.. | 233.40 | |
275 |
| gettex | 229.500 | |
52 |
| Stuttgart | 233.050 | |
48 |
| Frankfurt | 231.9000 | |
26 |
| München | 232.30 | |
20 |
| Berlin | 233.30 | |
14 |
| Hamburg | 226.15 | |
0 |
| Düsseldorf | 233.60 | |
0 |
| Hannover | 226.15 | |
0 |
| Lang & Schwa.. | 223.450 |  |
|
| Moscow | 20,276.00 | 556 | |
| Mexico | 5,571.19 | |
73 |
News
- Catalyst Biosciences Reports Fourth Quarter and Full-Year 2020 Operating & Financial Results and Provides a Corporate Update
03/04/2021 / 14:00 - GlobeNewswire - Biogen Announces Plans to Build a New, State-of-the-Art Gene Therapy Manufacturing Facility in Research Triangle Park, North Carolina
03/04/2021 / 13:47 - GlobeNewswire - Dyne Therapeutics Appoints Wildon Farwell, M.D., MPH, as Chief Medical Officer
03/04/2021 / 13:25 - GlobeNewswire - Purple Biotech Appoints Biopharmaceutical Industry Veteran Robert Gagnon to Board of Directors
03/03/2021 / 13:00 - GlobeNewswire - Artizan Biosciences Closes $11 Million Series A-2 Financing and Enters Option and License Agreement with Biohaven Therapeutics
03/01/2021 / 22:00 - GlobeNewswire
Real-time